HIFU Consultation and Consent: The Record That Protects You
HIFU consultation and consent is the cheapest part of the treatment and the part that decides how a complaint ends. Nobody re-reads your brochure when a client comes back unhappy. They read the file you built before the first shot.
The paperwork is what a complaint gets judged on
Picture how these go wrong. Six weeks on, a client says her jaw looks the same, or that one corner of her mouth felt lazy for a fortnight and nobody warned her. You believe you covered it. She believes you didn't. No photograph from the right angle, no line count, no note of what she asked for.
You lose that one. Not for treating badly, but for being unable to show what you did.
Build the file as though a stranger will read it. Our other buyer guides for HIFU clinics cover machines and margins. This one covers the twenty minutes before anyone picks up a handpiece.
Screen in this order, and write the answers down
Order matters. The first questions can end a consultation outright, and there's no sense taking a full history for a treatment you're about to refuse. Record the answer even when it's no. A blank line proves nothing later.
| Ask, in this order | Why it sits here | What a yes does |
|---|---|---|
| Any implanted device? Any metal in or near the area? Pacemaker, defibrillator, dental hardware, plates? | The Ulthera IFU makes active implants and metallic implants in the field an outright contraindication. Our RF protocol notes add large metallic dental implants. | Active implant: stop. Metal in the field: nothing over it, and map the exclusion zone first. |
| Anything active on the skin today? Open lesion, cystic acne, cold sore, rash? | The IFU contraindicates open wounds, lesions and severe or cystic acne in the field, and lists herpes simplex as not evaluated. | Reschedule. Heating inflamed tissue buys nothing and can buy pigment. |
| What have you had done, and on what date? Toxin, filler, threads, laser, RF? | Treatment isn't recommended directly over mechanical implants, dermal fillers or breast implants. Interval matters as much as substance. | Map filler and thread positions, then treat around them. See the interval note below. |
| Autoimmune disease, diabetes, bleeding disorder, anticoagulants, epilepsy, Bell's palsy, anything that slows healing? | The IFU has not evaluated the system in any of these groups, nor where skin disease may alter healing. | Not evaluated isn't the same as forbidden. It does move the risk onto you, so it needs a clinician's decision, written down. |
| Are you pregnant or breastfeeding? | Not evaluated in pregnancy, breastfeeding or children. | Defer, and book a review. |
| What are you hoping to see, and what have you tried? | UK GMC cosmetic guidance, in effect since 1 June 2016, requires you to ask why she wants it and what outcome she hopes for, before judging fit. | If you think it won't deliver, say so. If you still think so afterwards, don't provide it. |
The interval question nobody writes down
Recent injectables catch out careful clinics, because clients rarely volunteer a date. Ask for the month and the practitioner.
Our device manuals are stricter than most consent forms. A fractional laser manual in our engineering archive excludes patients within 7 days of botulinum toxin injection, within 7 days of light or RF treatment, and within 3 months of ablative resurfacing. Our skin basics training manual runs the rule the other way: no fillers for two weeks after an energy session, no direct or indirect heat for three days, extra caution for anyone whose skin readily holds pigment after inflammation.
Same logic, different modality. Pick your intervals, print them on the form as dates, apply them in both directions. Threads get their own line: you need to know where they run and when they went in, because focused ultrasound at 3.0mm and 4.5mm targets the planes a barbed suture lives in.
What consent has to convey to mean anything
A signature on boilerplate protects nobody. Consent means she can repeat back what she's buying and what could go wrong. Five things have to land.
What it can actually do. Tighten tissue that still has spring in it. The Ulthera indications are narrow and worth borrowing as a frame: lift the eyebrow, lift lax submental and neck tissue, improve lines and wrinkles of the décolleté. Nothing about fat, nothing about surgery.
The full range of outcomes, including nothing visible. A 2025 systematic review and meta-analysis in Aesthetic Surgery Journal found investigators rated 89% of patients improved and patients rated 84%, leaving roughly 11% to 16% with no aesthetic improvement at all. Satisfaction ran 84% overall, but only 62% in studies offering a neutral answer. Say it out loud. A client who has heard that number won't feel cheated by it.
Discomfort during delivery. The same review reports a pooled mean pain score of 4.85 on a 0 to 10 scale, 4.62 for face and neck and 5.58 for other body areas. Moderate, not nothing. Tell her it arrives in pulses and she can ask you to stop.
Nerve effects, and what you'll do about them. The conversation everyone skips.
| What she may notice | Typical course reported in the device IFU |
|---|---|
| Redness | Usually settles within a few hours |
| Swelling | Typically 3 to 72 hours |
| Welting | Typically within a week |
| Tenderness, bruising | Typically 2 days to 2 weeks |
| Muscle weakness from motor nerve inflammation | Typically 2 to 6 weeks |
| Numbness or tingling from sensory nerve inflammation | Typically 2 to 6 weeks |
The IFU records no permanent facial nerve injuries in its clinical trials, and warns that burns and possible scarring can follow bad technique: a tilted transducer, wrong line spacing, gel pockets. Both halves belong in the talk. Write the protocol before you need it. Photograph, date, review at two and six weeks, refer if it isn't moving.
The slow build. Collagen remodelling takes months, not days. Book the three-month review when you take the deposit, so the timeline reads as a plan and not an excuse invented later.
When the right answer is no
Some warning signs aren't medical at all.
- She brings a photograph of someone else's jaw.
- She's already unhappy with two previous clinics, in detail.
- She has a wedding in three weeks and wants it visible by then.
- Someone else is paying and doing most of the talking.
- She has a keloid in the field. The IFU says treatment energy is not recommended directly on one.
The GMC guidance is explicit: weigh a patient's vulnerabilities and psychological needs, and satisfy yourself the request is voluntary. Body dysmorphic concerns belong with a clinician who can assess and refer, not a room trying to fill a slot. Refusing costs one booking. Treating the wrong person costs a year of reviews.
The record: photographs, a map, settings, a name, and her words
Here's the part no supplier sells you. No margin in it.
Photographs. Fix camera position, distance, lighting, background and head angle, then reproduce all five every visit. Makeup off, jewellery off, hair back. A before shot under warm downlights and an after by a window proves nothing, and your client sees that too.
The treatment map. Our device manuals have shipped this discipline for years. The customer profile form and archive table bundled with our long-pulse laser manual capture treatment site, history, allergies, contraindications and output mode, then per session the treated area, number of focal spots, pulse interval and energy, plus the reaction at 24 hours and the skin condition 45 days after the first treatment. Old paperwork, right skeleton. Port it to ultrasound and you log zones, lines per zone, depth and energy.
The settings, tied to the hardware. On the HF-01 4D HIFU platform that means naming handle and cartridge, because the 4D handle carries 3.0mm and 4.5mm as standard with 6mm to 16mm optional, the V-max handle starts at 1.5mm, and the system runs at 4 to 7MHz with 12 lines per shot. A file reading "full face, 300 shots" tells a reviewer nothing. One saying which depth went where tells everything.
The operator. One name, signed. Log cartridge serial numbers against the client, so a questioned batch traces to everyone treated with it. GMC guidance asks for exactly that, plus written information detailed enough for another practitioner to take over care, and secure storage under data protection law.
Her goal, in her own words. Quote her, don't paraphrase. "I want my neck to look like it did two years ago" and "I want a jawline like my sister's" carry different risks, and only one is treatable. That sentence, in quotation marks and dated, is the most useful line in the file.
Who may treat, and what your form must say, is local
Don't copy a consent form off the internet, and don't treat a supplier's as legally sufficient. The Ulthera IFU notes that US federal law restricts that device to sale by or on the order of a physician, for use only by trained physicians or trained people under such supervision. UK doctors work under GMC guidance where consent must be sought by the doctor performing the intervention and cannot be delegated, and the patient must be told she can change her mind at any point. Other markets regulate operator, premises and retention period differently again.
What travels is the content: the screening order above, the five things consent must convey, the record fields. Take it to a local lawyer or your indemnity provider and let them turn it into your form. Ask us for the documentation, cartridge traceability and after-sales support behind the machine, then build the paperwork on top.
Evidence and further reading
Educational material for equipment buyers and operators. It is not medical advice, an operating protocol or a promise of clinical outcome.
- Ulthera, Inc. Ulthera System Instructions for Use, featuring DeepSEE technology for Ultherapy, 1015107IFU Rev A, 10-2021 (contraindications: open wounds or lesions in the treatment area, severe or cystic acne in the treatment area, active implants such as pacemakers or defibrillators, or metallic implants in the treatment area; treatment not recommended directly over mechanical implants, dermal fillers or breast implants, nor directly on an existing keloid; areas to avoid include the thyroid gland, thyroid cartilage and trachea, major vessels, and breast tissue or implants; not evaluated in patients on an anticoagulant treatment plan, in pregnant or breastfeeding women, in children, or in hemorrhagic disorder, hemostatic dysfunction, active systemic or local skin disease that may alter wound healing, herpes simplex, autoimmune disease, diabetes, epilepsy or Bell's palsy; side effects with reported time courses: erythema within a few hours, edema 3 to 72 hours, welting within a week, post-procedure discomfort 2 hours to 2 days, tenderness and bruising 2 days to 2 weeks, transient motor-nerve muscle weakness, sensory numbness, pain, paresthesia or tingling typically 2 to 6 weeks, with no permanent facial nerve injuries reported in clinical trials; burns and possible scarring may follow incorrect technique such as tilting the transducer, incorrect line spacing or gel pockets; indications are lifting the eyebrow, lifting lax submental and neck tissue, and improving lines and wrinkles of the decollete; US federal law restricts the device to sale by or on the order of a physician and it is intended for use only by properly trained physicians or properly trained persons under such supervision)
- General Medical Council. Guidance for doctors who offer cosmetic interventions. Published 12 April 2016, in effect 1 June 2016 (paragraph 16: the doctor carrying out the intervention must discuss it and seek consent and must not delegate that responsibility; paragraph 17: you must ask the patient why they want the intervention and the outcome they hope for before assessing whether it is appropriate; paragraph 18: if you still believe after discussion that the intervention will not benefit the patient, you must not provide it; paragraph 19: you must consider the patient's vulnerabilities and psychological needs and satisfy yourself that the request is voluntary; paragraph 23: you must discuss adverse outcomes and the physical and psychological impact of the intervention going wrong or failing to meet expectations; paragraph 26: you must tell the patient they can change their mind at any point; paragraph 39: written information detailed enough for another doctor to take over care; paragraph 40: records organised so patients treated with a particular device can be identified in the event of product safety concerns; paragraph 41: records kept securely and in line with data protection requirements)
- Amiri M, Ajasllari G, Llane A, et al. Microfocused Ultrasound With Visualization (MFU-V) Effectiveness and Safety: A Systematic Review and Meta-Analysis. Aesthetic Surgery Journal 2025;45(3):NP86-NP94, doi:10.1093/asj/sjae228 (pooled mean pain score 4.85 on a 0 to 10 scale, 4.62 for face and neck and 5.58 for other body areas; investigator-rated improvement 89% and patient-rated improvement 84%, leaving roughly 11% to 16% with no aesthetic improvement; overall satisfaction 84%, falling to 62% in studies offering a neutral response option; most frequent complications erythema, edema, swelling, bruising and tenderness, all mild or moderate, with no acute skin damage or long-term sequelae such as nerve or muscle dysfunction, scarring, ulceration, hypopigmentation or hyperpigmentation reported across the included studies)
Keep reading
Ready to spec your next machine?
Tell us the indication, your market and the certifications you need. Our export team replies with a configuration and quotation within 12 to 24 hours.